Avedro, Inc. Announces Preparation for Anticipated Hyperopic Lasik Xtra® U.S. Clinical Trial
3/13/2013 9:05:36 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Avedro today announced that in preparation for its US clinical trial, a select group of US refractive surgeons have just completed Lasik Xtra procedure training under Gustavo Tamayo, MD, at the Bogota Laser Center in Bogota, Colombia. Lasik Xtra is a two minute procedure used in conjunction with standard LASIK to provide added strength and stability to the cornea during and after a Lasik procedure. Already in use throughout the world, Avedro’s Lasik Xtra combines riboflavin (vitamin B2) ophthalmic solution with Avedro’s KXL® System (UVA irradiation) to achieve accelerated corneal crosslinking during LASIK.
comments powered by